SF
DERM icon

Summit Financial’s Journey Medical DERM Stock Holding History

Summit Financial’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Sell
346,748
-33,059
-9% -$189K 0.03% 581
2026
Q1 		$1.78M Sell
379,807
-10,612
-3% -$82.4K 0.02% 608
2025
Q4 		$3.01M Buy
390,419
+10,590
+3% +$83K 0.04% 379
2025
Q3 		$2.7M Buy
+379,829
New +$2.76M 0.04% 403

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Summit Financial's DERM Position: Q2 2026 in Review

Summit Financial reduced its Journey Medical (DERM) stake by 8.7% in Q2 2026, selling an estimated $189K and leaving 346,748 shares worth $2.45M. The position accounts for 0.03% of the portfolio, ranked #581.

Summit Financial first reported a position in DERM in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.01M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Summit Financial held 346,748 shares of Journey Medical worth $2.45M as of Q2 2026.
  • Summit Financial sold 33,059 Journey Medical shares in Q2 2026, an estimated $189K.
  • Journey Medical made up 0.03% of Summit Financial's portfolio in Q2 2026, its #581 holding.
  • Summit Financial first reported a position in Journey Medical in Q3 2025 and has held it in 4 quarters since.
  • Summit Financial's Journey Medical position peaked at $3.01M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.